WELCOME TO DR. VITUS BLOG

NEWS | SPORTS | ECONOMICS | MAKE MONEY | DIRECTORY | STORY | TECH | POEMS

SUMMIT ARTICLE | ADVERTISE | OVEM

Tags

Recent Comments

Powered by Blogger.

DRVITUS BLOG NOTICE

© APRAIL 2019 - AND MORE... DRVITUS BLOG, A PRODUCT OF JLC MEDIA. ADVERT CALL, 08068488422. All Rights Reserved.

DRVITUS BLOG is not responsible for the content of external sites.

https://www.storystar.com/story/17224/okechukwu-chidoluo-vitus/true-life/love-romance-2

For Registering Domain Names, I trust DomainKing.NG






Travelstart Banner


www.apcwo.org / contact@apcwo.org

Recent Posts

Featured Post

DRVB PAPER

Followers

Total Pageviews

Blog Archive

Labels

JOIN US ON FACEBOOK

Amazine free articles

Latest Posts

Video of the day

Instagram

  • Alto Adds $50m to Expand
    Online Pharmacy
    Start-up pharmacy marketplace Alto
    Pharmacy has added additional $50
    million in a Series C funding round,
    adding to its venture capital sufficient
    amounts to push ahead with its
    expansion strategy that would allow the
    company to establish a truly nation-
    wide footprint well across the United
    States.
    Alto Pharmacy was created back in
    2015, after the acquisition of AG
    Pharmacy, which is a brick-and-mortar
    pharmacy based in San Francisco. The
    AG Pharmacy brand is an established
    local player with 30 years to its name,
    and Alto Pharmacy is its reinvented
    digital alter ego.
    As a result, Alto Pharmacy is one of
    the leading online pharmacies where
    you can get same-day prescription
    deliveries, along with a number of other
    services that are readily available on the
    cards.
    The company originally started
    operating under the name of ScriptDash,
    which better captured the instant nature
    of the company, but as more private
    equity began flowing into the company,
    so they decided to change it for
    marketing purposes.
    It was at around time that the company
    rose $23 million during a Series B
    funding round, which helped it hit new
    markets in Los Angeles. With the fresh
    $50 million, the company will seek to
    prove itself even more, establishing a
    truly national footprint.
    Alto will seek to double up on its
    efforts and see if it can break into new
    areas well beyond San Francisco and
    Southern California. But apart from
    scalability, the venture firm will also
    seek to improve-upon its existing offer
    and bring more people onboard with
    what it has to offer, guaranteeing the
    reach and quality of its service.
    Alto is also extending its offer to drug
    makers, offering to take the medicine
    off their hands and deliver it straight to
    people’s homes, which will cut the
    middlemen from the process and add
    value to all parties in the chain.
    Presently, Alto uses estimated 400
    chain pharmacy locations to ensure that
    deliveries are done within the same day
    and that people get the medicine that
    they have ordered. Alto is acting as a
    delivery service and the company
    focuses on expanding and creating
    healthy connections between patients
    and pharmacies rather than handling the
    drugs themselves.
    This exempts the company from any
    legal complications further down the
    road. Alto is fully prepared to address
    any future complications that may
    originate from the delivery system
    although the company’s executives are
    sure that Alto will not slip when it
    comes to carry out a specific delivery.
    Alto is operating in a highly-competitive
    sector, which means that the company
    will need to find itself a place in niches
    and then push back against giants,
    such as Amazon. Amazon has been
    dominating a lot of the online
    commerce in the states and this is only
    likely to spill over other sectors.
    However, Alto’s offer is comprehensive
    enough for the company to have
    guaranteed itself strong bastions well
    across the United States, making it
    completely resilient against unfair
    competition.

    No comments:

    Post a Comment